RecruitingPHASE1, PHASE2NCT07064018

Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies

Studying Soft tissue sarcoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of California, Irvine
Principal Investigator
Warren Chow, MD
Chao Family Comprehensive Cancer Center
Intervention
Spedox-6(drug)
Enrollment
67 enrolled
Eligibility
18 years · All sexes
Timeline
20252031

Study locations (1)

Collaborators

Sunstate Biosciences LLC

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07064018 on ClinicalTrials.gov

Other trials for Soft tissue sarcoma

Additional recruiting or active studies for the same condition.

See all trials for Soft tissue sarcoma

← Back to all trials